Renew Your Membership

ACCEL Lite: AHA Late-Breaker SPEC-AI: Screening for Peripartum Cardiomyopathies Using an AI-Enhanced Digital Stethoscope: A Randomized Clinical Trial

Detecting HF (cardiac dysfunction) during pregnancy and shortly after having a baby can be challenging for health care professionals and is often delayed. The use of a device powered by artificial intelligence can assist health care providers in identifying this condition earlier.

In this interview, Demilade A. Adedinsewo MD, FACC, and Steven E. Nissen MD, MACC, discuss the AHA Late-Breaker: Screening for Peripartum Cardiomyopathies Using an Artificial Intelligence Enhanced Digital Stethoscope: A Randomized Clinical Trial.

Related References:

  1. Adedinsewo DA, Morales-Lara AC, Dugan J, Garzon-Siatoya WT, Yao X, Johnson PW, Douglass EJ, Attia ZI, Phillips SD, Yamani MH, Tobah YB, Rose CH, Sharpe EE, Lopez-Jimenez F, Friedman PA, Noseworthy PA, Carter RE. Screening for peripartum cardiomyopathies using artificial intelligence in Nigeria (SPEC-AI Nigeria): Clinical trial rationale and design. Am Heart J. 2023 Jul;261:64-74. doi: 10.1016/j.ahj.2023.03.008. Epub 2023 Mar 25. PMID: 36966922.

Clinical Topics: Heart Failure and Cardiomyopathies, Acute Heart Failure, Noninvasive Imaging

Keywords: ACCELLite, Artificial Intelligence, Cardiomyopathies, AHA23, Heart Failure

< Back to Listings